|
Market Closed -
Börse Stuttgart
05:46:14 05/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 129.48 EUR | -0.43% |
|
+1.90% | +22.93% |
| 03/09 | AbbVie's blood cancer therapy lowers disease progression, death risk in trial | RE |
| 01/09 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| Market Cap | 187B 161B 152B 138B 259B 17,677B 260B 1,791B 695B 9,070B 703B 688B 29,218B | P/E 2026 * |
-46.1x | P/E 2027 * | 18.8x |
|---|---|---|---|---|---|
| Enterprise Value | 204B 176B 165B 151B 282B 19,258B 283B 1,951B 757B 9,881B 766B 749B 31,831B | EV / Sales 2026 * |
6.65x | EV / Sales 2027 * | 6.01x |
| Free-Float |
99.88% | Yield 2026 * |
2.18% | Yield 2027 * | 2.25% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GILD | Delayed | |
CBOE
| GILD | Real-time | |
|
Tradegate
| GIS | Real-time | |
|
London S.E.
| 0QYQ | Delayed | |
|
Boerse Muenchen
| GIS | Real-time | |
|
Wiener Boerse
| GILD | End-of-day quote | |
|
Mexican S.E.
| GILD * | End-of-day quote | |
|
Xetra
| GIS | Delayed | |
|
Borsa Italiana
| 1GILD | End-of-day quote | |
|
CBOE
| 0QYQ | Real-time | |
|
Swiss Exchange
| GILD | Delayed | |
|
Santiago S.E.
| GILDCL | End-of-day quote | |
|
Deutsche Boerse AG
| GIS | Delayed | |
|
Lima
| GILDUS | End-of-day quote | |
|
Santiago S.E.
| GILD | End-of-day quote | |
|
Börse Stuttgart
| GIS | Delayed | |
|
Swiss Exchange
| GILD | Delayed | |
|
CBOE
| Real-time |
Last Transcript : Gilead Sciences, Inc.
| 1 week | +3.14% | ||
| Current month | +2.91% | ||
| 1 month | +11.64% | ||
| 3 months | +16.48% | ||
| 6 months | +1.70% | ||
| Current year | +22.40% |
| 1 week | 124.3 |  | 130.06 |
| 1 month | 112.02 | | 130.06 |
| 3 years | 57.32 | | 132.16 |
| 5 years | 52.29 | | 132.16 |
| 10 years | 46.26 | | 132.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 01/03/2019 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 01/11/2019 |
Keeley Wettan
CMP | Compliance Officer | - | 18/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 19/08/2016 |
| Director/Board Member | 73 | 01/01/2018 | |
Harish Manwani
BRD | Director/Board Member | 72 | 09/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.43% | +1.90% | +32.94% | +82.11% | 187B | |
| -0.88% | -2.15% | +58.05% | +105.91% | 1,024B | |
| -1.15% | +2.68% | +54.25% | +71.29% | 663B | |
| -1.44% | +0.38% | +20.65% | +75.54% | 453B | |
| +0.14% | -0.47% | +30.20% | +40.61% | 352B | |
| -1.33% | +4.72% | +24.62% | +47.60% | 304B | |
| -1.15% | +0.30% | -0.69% | +11.83% | 252B | |
| -1.55% | +1.11% | +54.15% | +72.13% | 236B | |
| -0.88% | +1.15% | -14.60% | -54.84% | 206B | |
| -0.15% | +3.65% | +31.24% | +100.90% | 187B | |
| Average | -0.93% | +1.09% | +29.08% | +55.31% | 408.71B | |
| Weighted average by Cap. | -0.96% | +0.55% | +37.40% | +67.73% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.69B 26.41B 24.85B 22.7B 42.46B 2,897B 42.57B 294B 114B 1,487B 115B 113B 4,789B | 32.68B 28.12B 26.46B 24.17B 45.21B 3,085B 45.33B 313B 121B 1,583B 123B 120B 5,100B |
| Net income | -4.27B -3.68B -3.46B -3.16B -5.91B -404B -5.93B -40.9B -15.87B -207B -16.05B -15.7B -667B | 10.28B 8.84B 8.32B 7.6B 14.22B 970B 14.25B 98.3B 38.14B 498B 38.58B 37.74B 1,603B |
| Net Debt | 16.75B 14.41B 13.56B 12.38B 23.17B 1,581B 23.23B 160B 62.16B 811B 62.88B 61.51B 2,613B | 9.12B 7.85B 7.39B 6.75B 12.62B 861B 12.66B 87.29B 33.87B 442B 34.26B 33.52B 1,424B |
| Date | Price | Change |
|---|---|---|
| 04/09/26 | EUR 129.48 | -0.43% |
| 03/09/26 | EUR 130.04 | +0.57% |
| 02/09/26 | EUR 129.30 | +0.42% |
| 01/09/26 | EUR 128.76 | +2.34% |
| 31/08/26 | EUR 125.82 | +0.22% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
- GIS Stock
Select your edition
All financial news and data tailored to specific country editions
